Curated News
By: NewsRamp Editorial Staff
November 13, 2026

SS Innovations Promotes Dr. Vishwa Srivastava to President, Appoints Gary Lo as CFO

TLDR

  • SS Innovations promotes Dr. Vishwa Srivastava to president and names Gary Lo CFO to drive U.S. expansion of its SSi Mantra surgical robot.
  • SS Innovations advances FDA 510(k) responses and EU CE marking for its SSi Mantra system while finalizing new healthcare technologies from its India R&D facility.
  • SS Innovations aims to make robotic surgery affordable and accessible globally, potentially improving surgical outcomes for more patients.
  • The SSi Mantra surgical robot features up to five arms, 3D 4K visualization, and has been clinically validated in over 190 procedure types in India.

Impact - Why it Matters

The promotion of Dr. Vishwa Srivastava and appointment of Gary Lo come at a critical juncture for SS Innovations as it navigates FDA review and European certification for its SSi Mantra surgical robotic system. With Srivastava’s focus on U.S. expansion and Lo’s financial expertise, the company is positioning itself to compete in the global surgical robotics market, where affordable alternatives to established systems are in demand. The leadership changes could accelerate the commercialization of SSi Mantra, potentially increasing access to robotic surgery in underserved markets and driving growth for SSII investors.

Summary

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has promoted Dr. Vishwa Srivastava to president and appointed Gary Lo as chief financial officer. Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building its U.S. business and leading global operations. Both executives are based in the United States. Lo brings more than three decades of financial leadership experience across technology companies, including the medical technology sector, with expertise in capital markets, financial planning and strategic growth.

The leadership changes come as SS Innovations advances its international expansion plans for the SSi Mantra surgical robotic system. The company is responding to questions from the U.S. Food and Drug Administration (“FDA”) regarding its 510(k) premarket notification while pursuing CE marking certification in the European Union. SS Innovations is also finalizing a pipeline of additional health care technologies at its research and development facility in India, with plans to introduce them in the coming months. To view the full press release, visit https://nnw.fm/dX3qc.

SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.

The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII

Source Statement

This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Promotes Dr. Vishwa Srivastava to President, Appoints Gary Lo as CFO

Blockchain registration record for this content